SCAF11 and infectious otitis media: Consistent with the enhanced tumorigenesis observed in Casp11−/− mice, we observe defective STAT1 activation in caspase-11 deficient AOM-DSS-treated mice at both advanced (15 week) and progression (6 week) stages of CAC.